WDC
GBT

Woodward Diversified Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Woodward Diversified Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,930
Closed -$418K – 230
2021
Q2 		$418K Sell
11,930
-2,487
-17% -$97.1K 0.24% 105
2021
Q1 		$587K Sell
14,417
-5,990
-29% -$275K 0.35% 74
2020
Q4 		$884K Buy
+20,407
New +$1.01M 0.57% 53

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Woodward Diversified Capital's GBT Position: Q3 2021 in Review

Woodward Diversified Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 11,930 shares — an estimated $418K sold.

Woodward Diversified Capital first reported a position in GBT in Q4 2020 and held it in 3 quarters. The position peaked at $884K in Q4 2020. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Woodward Diversified Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Woodward Diversified Capital sold 11,930 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $418K.
  • Woodward Diversified Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
  • Woodward Diversified Capital's Global Blood Therapeutics, Inc. position peaked at $884K in Q4 2020.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Woodward Diversified Capital's 13F filing for Q3 2021, filed 4 Nov 2021.